Metoprolol + metoprolol plus morphine
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Coronary Syndromes
Conditions
Acute Coronary Syndromes
Trial Timeline
— → —
NCT ID
NCT00718406About Metoprolol + metoprolol plus morphine
Metoprolol + metoprolol plus morphine is a approved stage product being developed by AstraZeneca for Acute Coronary Syndromes. The current trial status is completed. This product is registered under clinical trial identifier NCT00718406. Target conditions include Acute Coronary Syndromes.
What happened to similar drugs?
20 of 20 similar drugs in Acute Coronary Syndromes were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00718406 | Approved | Completed |
Competing Products
20 competing products in Acute Coronary Syndromes